As of 2025-05-16, the Intrinsic Value of Pfizer Ltd (PFIZER.NS) is 1,905.65 INR. This PFIZER.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 4,459.20 INR, the upside of Pfizer Ltd is -57.30%.
The range of the Intrinsic Value is 1,681.38 - 2,255.21 INR
Based on its market price of 4,459.20 INR and our intrinsic valuation, Pfizer Ltd (PFIZER.NS) is overvalued by 57.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 1,681.38 - 2,255.21 | 1,905.65 | -57.3% |
| DCF (Growth 10y) | 1,892.76 - 2,479.29 | 2,124.75 | -52.4% |
| DCF (EBITDA 5y) | 3,467.29 - 3,935.86 | 3,734.26 | -16.3% |
| DCF (EBITDA 10y) | 3,187.91 - 3,843.06 | 3,526.01 | -20.9% |
| Fair Value | 799.37 - 799.37 | 799.37 | -82.07% |
| P/E | 4,688.21 - 5,852.49 | 4,992.32 | 12.0% |
| EV/EBITDA | 3,237.51 - 4,595.05 | 4,216.69 | -5.4% |
| EPV | 1,422.20 - 1,603.38 | 1,512.79 | -66.1% |
| DDM - Stable | 756.49 - 1,518.98 | 1,137.73 | -74.5% |
| DDM - Multi | 1,124.40 - 1,709.61 | 1,353.25 | -69.7% |
| Market Cap (mil) | 204,008.40 |
| Beta | 0.57 |
| Outstanding shares (mil) | 45.75 |
| Enterprise Value (mil) | 182,225.60 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.21% |
| Cost of Debt | 6.07% |
| WACC | 14.16% |